Combination treatment with rituximab and belimumab in shrinking lung syndrome in systemic lupus erythematosus
Adriana C. Esteves,
Beatriz Mendes,
Helena Assunção
et al.
Abstract:We report the case of a Caucasian, non-smoker, 66-year-old female with systemic lupus erythematosus (SLE) for over 20 years, with cumulative mucocutaneous, articular, hematologic, serosal, and serologic involvement. Due to persistent polyarthritis and recurrent episodes of pleural effusion despite maintenance treatment with prednisolone 10 mg/day, hydroxychloroquine 400 mg/day, and subcutaneous methotrexate 25 mg/week, intravenous belimumab 10 mg/kg was initiated as add-on therapy in July 2020, allowing
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.